CANOF yields 964.60% · JNJ yields 2.13%● Live data
📍 CANOF pulled ahead of the other in Year 1
Combined, CANOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CANOF + JNJ for your $10,000?
California Nanotechnologies Corp. engages in the research, development, and production of nano-structured components and materials. The company provides spark plasma sintering (SPS); cryogenic milling; SPS/fast tooling; wire electrical discharge machining; planetary milling and particle size analysis; hot pressing tooling fabrication and design; tensile, compression, and hardness testing; planetary ball milling; V-blending/ tumble milling; particle size analysis through laser diffraction; and metals and metallic alloys machining services. It also offers SPS starter accessory kits, SPS graphite tooling, spark plasma sintering machines, tungsten carbide tooling, SPS graphite crucibles, carbon graphite foil/paper, carbon felt, and yarn and quartz glass windows. It serves microchip fabrication, aerospace, sports and recreation, defense, automotive, medical, and the oil and gas industries. The company is headquartered in Cerritos, California.
Full CANOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.